Ali-Jackson Kamil (CIK 0001654337)

Latest company ownership

ACRS - Aclaris Therapeutics, Inc.
Role: Chief Legal Officer
Shares held
28,400
Last filed at
Jan 5, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q3 2025Q4
Shares held
9,000
Last filed at
Jun 25, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 15, 2021 Jun 17, 2021 PDS Biotechnology Corp Director Buy 95.0 +11,764 100.00% ✗ $100K
Jun 3, 2021 Jun 4, 2021 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 32.5 -9,492 -7.21% ✓ $208.4K
Jun 1, 2021 Jun 2, 2021 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 7.5 -45,119 -25.52% ✓ $997K
May 6, 2021 May 7, 2021 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 35.0 -20,416 -3.40% ✓ $478.8K
May 3, 2021 May 5, 2021 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 32.5 -45,000 -4.93% ✓ $1.1M
Mar 1, 2021 Mar 3, 2021 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 42.5 -6,840 -2.36% ✗ $163K
Feb 1, 2021 Feb 3, 2021 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 46.3 -1,318 -1.03% ✗ $28.1K
Dec 15, 2020 Dec 17, 2020 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 52.5 -498 -0.40% ✗ $2.3K
Jun 1, 2020 Jun 3, 2020 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 46.3 -9,534 -7.20% ✗ $12.6K
Mar 2, 2020 Mar 4, 2020 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 47.5 -4,779 -4.60% ✗ $6K
Feb 3, 2020 Feb 4, 2020 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 47.5 -1,318 -1.50% ✗ $1.7K
Dec 18, 2019 Dec 20, 2019 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 52.5 -277 -0.33% ✗ $501.4
Dec 16, 2019 Dec 18, 2019 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 50.0 -497 -0.59% ✗ $894.6
Feb 1, 2019 Feb 5, 2019 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 47.5 -1,308 -1.57% ✗ $9.1K
Dec 18, 2018 Dec 20, 2018 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 52.5 -306 -0.38% ✗ $1.9K
Dec 15, 2018 Dec 18, 2018 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 50.0 -493 -0.62% ✗ $3.6K
Jun 11, 2018 Jun 12, 2018 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 32.5 -5,000 -6.05% ✓ $100K
May 18, 2018 May 21, 2018 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 25.0 -10,000 -10.79% ✓ $200K
May 7, 2018 May 9, 2018 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 46.3 -1,974 -2.09% ✗ $35.7K
Dec 15, 2017 Dec 21, 2017 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 48.8 -854 -0.54% ✗ $20.7K
Dec 18, 2016 Dec 20, 2016 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 51.3 -327 -0.42% ✗ $10.2K
Oct 26, 2016 Oct 28, 2016 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 37.5 -3,912 -4.90% ✓ $85.4K
Sep 28, 2016 Sep 28, 2016 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 45.0 -1,841 -2.37% ✓ $45.4K
Aug 26, 2016 Aug 29, 2016 Aclaris Therapeutics, Inc. Chief Legal Officer Sell 20.0 -3,738 -15.56% ✓ $76.1K